LSC Webinars
-
Breaking Barriers: Combining Cell Line Development Innovation With Improved Process Development Workflows To Streamline Path To FIH
10/16/2024
Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
-
From Crisis To Confidence: Ensuring Smooth Regulatory Submissions
10/8/2024
Explore some of the major challenges that medical writing submission specialists face today and strategies that can consistently set the stage for success.
-
Strategic Antibody Outsourcing: Guidance On Selection, Services, And Facility Fit
9/24/2024
How do you choose the best CDMO for your program? In this presentation, experts share insights and best practices on selecting, qualifying, and managing CDMO partnerships.
-
Advances In Oral GLP-1 Analogs For Obesity
9/12/2024
Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.
-
Developing High Concentration Biopharmaceuticals: Formulation Considerations
9/11/2024
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.
-
Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions
9/10/2024
Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.
-
Novel Chromatography For Antibody Variants And Recombinant Proteins
9/5/2024
Watch to explore key considerations for developing purification processes for bispecific antibodies and learn about an innovative affinity chromatography technology for purifying any recombinant protein.
-
Antibody-Drug Conjugate (ADC) – From Bioassay Development To Linker-Payload Constructs
8/29/2024
ADCs have emerged as a promising class of targeted cancer therapies. Explore linker-payload design elements, conjugation and characterization of ADCs, and the different bioassays used to screen ADCs.
-
Transforming Safety: A Customer Centric Model For Patients And Employees
8/19/2024
Explore unique infrastructure around safety operations and quality, with a focus on a new product introduction process with respect to risk assessment.
-
Building An Effective Contamination Control Strategy For Final Sterile Filtration
8/13/2024
Watch to learn about important considerations for final sterile filtration throughout product development and for performing pre-use post-sterilization integrity testing.